🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Material Elimination

According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.

After minutes of joining one community, a seller shared contact information, where the majority of purchases occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Product Details and Costs

Within these communities, messages display black plastic parcels with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly significant health risks”.